Formulation of patient dose of 177Lu-DOTA-TATE in hospital radiopharmacy in India: preparation using in situ methodology vis-a-vis freeze-dried kit

dc.contributor.authorDas, T.
dc.contributor.authorBanerjee, S.
dc.date.accessioned2015-09-01T09:35:32Z
dc.date.available2015-09-01T09:35:32Z
dc.date.issued2014
dc.description.divisionRC&IGen
dc.format.extent3323 bytes
dc.format.mimetypetext/html
dc.identifier.sourceCancer biotherapy & radiopharmaceuticals, 2014. Vol. 29 (7): pp. 301-302en
dc.identifier.urihttp://hdl.handle.net/123456789/11615
dc.language.isoenen
dc.subjectpatient doseen
dc.subject177Lu-DOTA-TATEen
dc.subjecthospital radiopharmacyen
dc.subjectIndiaen
dc.subjectin situ methodology vis-a-vis freeze-dried kiten
dc.titleFormulation of patient dose of 177Lu-DOTA-TATE in hospital radiopharmacy in India: preparation using in situ methodology vis-a-vis freeze-dried kiten
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1650.htm
Size:
3.25 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections